Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

3rd International Definiens Symposium to be Held in Munich from June 14-16, 2012

Published: Monday, April 23, 2012
Last Updated: Monday, April 23, 2012
Bookmark and Share
Program features latest trends in quantitative digital pathology and tissue-based biomarker development with leading experts from Roche, AstraZeneca, Novartis and cutting-edge biomedical image and data analysis during hands-on workshops.

Definiens® invites professionals interested in pathology and biomarker development to the 3rd International Definiens Symposium. The symposium will be held at the Definiens headquarters in Munich from June 14-16, 2012.

The annual event is the premier forum for the latest trends in quantitative research in histology, tissue-based biomarker development and cutting-edge biomedical image and data analysis. It brings together experts from around the world to share best practices and experiences. This year’s keynote lecture will be delivered by Dr. Frauke Bentzien from Exelixis, one of the pioneers in quantitative digital pathology who has been successfully applying this new paradigm in preclinical safety studies and clinical trials for many years.

The Definiens Symposium offers attendees the opportunity to network with peers and renowned experts and learn from their approaches and experiences. A one-day pre-conference workshop will provide hands-on experiences and training on the latest Definiens solutions for image analysis and data mining.

Nobel Laureate Prof. Gerd Binnig, Founder and CTO Definiens, will share his vision for the next generation of pathology tools, while leading experts from Roche, AstraZeneca, Novartis, GlaxoSmithKline and Johnson & Johnson, as well as practitioners from other renowned institutions, will contribute insights from their work. To find the full speaker panel and the workshop program, visit http://www.definiens.com/community/symposium.html.

“We are delighted to have such a distinguished group of speakers,” stated Thomas Heydler, CEO of Definiens. “The digital pathology market is quickly transitioning into a second phase of adoption where quantitative approaches allow us to unveil the real value of digital slides and are currently transforming pathology into a quantitative discipline. By bringing together thought leaders, experts and users, the International Definiens Symposium provides a very stimulating forum for learning about the future of this exciting field.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
New Therapeutic Target for Crohn’s Disease
A promising new target for drugs that treat IBD has been identified along with a possible biomarker for IBD severity.
Uncovering Water Bear Resilience
A protein identified in water bears can protect DNA of human cells from lethal doses of radiation damage.
Potential of New Insect Control Traits in Agriculture
Researchers have discovered a protein that shows promise as an alternate corn rootworm control mechanism.
Peer Reviewed Study Demonstrates Mass Spec Technique
The peer reviewed study demonstrates MS workflow, TMTCalibrator workflow, which dramatically enhances detection of key early stage Alzheimer’s biomarkers.
Enhancing Antibiotics to Defeat Resistant Bacteria
Scientists enhance ability of antibiotics to defeat resistant types of bacteria using molecules called PPMOs
Disordered Protein 'Shape Shifts' to Avoid Crowding
Study suggests disordered protein escapes from the cell membrane when it runs out of space.
Hyperstable Peptides for 'On-Demand' Drugs
These small molecules can fold into different conformations that could allow for greater flexibility in precision drug design
Antibodies Block Norovirus’ Entrance into Cells
Scientists have uncovered a mechanism in the human body that targets and successfully blocks noroviruses.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!